Evaluating and managing odynophagia in clinical practice

Odynophagia, the medical term for painful swallowing, is a symptom that can signal anything from a transient mucosal irritation to a serious underlying oesophageal disorder. Unlike dysphagia, which describes difficulty moving a bolus from mouth to stomach, odynophagia is defined by the quality of pain that accompanies swallowing, often described as a burning, squeezing, or sharp retrosternal sensation. Learn more about リウマチ診療の初診時に確認すべき患者の全身状態の評価法.

For clinicians working along the Australian east coast, where case mixes include both urban tertiary referrals and patients from regional New South Wales or Queensland, the differential can be broad. The evaluation pathway must therefore be efficient enough to avoid missing malignancy yet pragmatic enough to manage common benign causes without overwhelming outpatient resources.

This overview walks through the clinical reasoning behind assessing painful swallowing, the investigations that typically clarify the cause, and the treatment options available within Australian prescribing and reimbursement frameworks. A practical lens is offered throughout, with attention to when telehealth, public hospital waiting lists, or specialist referral become part of the management plan.

Defining the symptom and separating it from related complaints

Odynophagia refers specifically to pain triggered by the act of swallowing, whether the bolus is solid, liquid, or even saliva. Patients may describe it as a burning retrosternal discomfort, a sharp catch, or a persistent ache that worsens during meals. It is important to distinguish this from dysphagia, which implies a mechanical or motility-related impediment rather than a painful sensation.

Globus sensation, sometimes reported as a lump in the throat, is yet another entity and usually reflects muscular tension or reflux rather than true oesophageal pain. Sorting these out at the first consultation shapes the subsequent work-up and prevents unnecessary testing for the wrong complaint.

A focused history should establish the timing of pain in relation to swallowing, the duration of symptoms, associated features such as weight loss or odynophagia with medication, and any precipitating events including recent infections or new prescriptions.

Common underlying causes

Infectious oesophagitis remains a frequent culprit, particularly in immunocompromised patients, those on inhaled or systemic steroids, and individuals living with HIV. Candida, herpes simplex, and cytomegalovirus can all produce severe odynophagia, sometimes with visible oral thrush as a clue.

Pill-induced oesophagitis is a recurring problem in Australian general practice, where medications such as bisphosphonates, doxycycline, NSAIDs, and slow-release potassium are widely prescribed. Taking these with insufficient water or immediately before lying down increases the risk of mucosal injury.

Other causes include eosinophilic oesophagitis, which is increasingly recognised in both adult and paediatric populations, reflux-related ulceration, radiation injury in head and neck cancer survivors, and, critically, oesophageal malignancy, which must be excluded in any patient with new, progressive, or unexplained painful swallowing.

Clinical assessment at the bedside

A careful history typically points toward the most likely cause before investigations begin. Ask about the character of pain, whether it occurs with solids, liquids, or both, and any temporal relationship to meals or medications. Red flags such as weight loss, haematemesis, anaemia, or vomiting warrant urgent referral.

Examination should include inspection of the oral cavity and oropharynx, palpation of the neck for lymphadenopathy or thyroid enlargement, and basic observations including hydration status. A brief cardiovascular and respiratory assessment is reasonable given that atypical cardiac pain can occasionally mimic oesophageal discomfort.

In regional settings, where access to gastroenterology may require travel to Brisbane or Sydney, primary care clinicians often initiate empirical therapy while arranging expedited endoscopy. Documentation of symptom severity using a simple visual analogue score can help track response over time.

Diagnostic work-up and imaging

Upper endoscopy is the cornerstone of investigation, allowing direct visualisation of the mucosa, targeted biopsies, and therapeutic intervention where needed. In Australia, this can be obtained through public hospitals with typical waiting times of several weeks, or more quickly through private providers using Medicare-funded referrals.

Barium swallow studies retain a role when endoscopy is inconclusive or when motility disorders are suspected, though their sensitivity for subtle mucosal disease is limited. High-resolution manometry is reserved for cases where a primary motor disorder is suspected after structural causes have been excluded.

Laboratory tests are not always required, but a full blood count, iron studies, and inflammatory markers can support suspicion of anaemia, infection, or systemic inflammation. For patients with rheumatological comorbidities, a broader systemic assessment is often valuable, and the rheumatology evaluation framework provides a useful starting point.

Treatment approaches

Treatment depends on the identified cause. For pill-induced oesophagitis, withdrawal of the offending agent, switching to a liquid formulation where available, and a brief course of a proton pump inhibitor usually resolves symptoms. TGA-approved PPIs are listed on the Pharmaceutical Benefits Scheme, making them accessible at subsidised cost.

Infectious oesophagitis requires pathogen-directed therapy: antifungal agents for candidiasis, aciclovir or valaciclovir for herpes, and ganciclovir for cytomegalovirus in immunocompromised hosts. Topical anaesthetic preparations such as lignocaine viscous can provide interim symptomatic relief while definitive treatment takes effect.

For eosinophilic oesophagitis, dietary elimination strategies, swallowed topical corticosteroids, and endoscopic dilation in selected cases form the mainstay. Patients with refractory symptoms may benefit from biologic therapies now emerging in Australian specialist practice.

Working within Australian healthcare systems

Australian clinicians navigate a mixed public and private system, where PBS listings, Medicare rebates, and local hospital pathways shape day-to-day decisions. Public endoscopy waiting lists in cities like Adelaide or Perth can be substantial, prompting many GPs to refer privately or initiate empirical treatment while awaiting review.

Telehealth has become embedded in routine care, particularly since the pandemic, allowing regional patients in Western Australia or Far North Queensland to access specialist input without long-distance travel. This is particularly useful for medication reviews and follow-up after endoscopy.

Multidisciplinary clinics combining gastroenterology, ENT, allergy, and dietetics are concentrated in major tertiary centres, though outreach services and shared-care arrangements are extending their reach. Cultural safety matters, and Aboriginal and Torres Strait Islander patients benefit from services that acknowledge both clinical and community context.

When to refer and escalate

Referral to a gastroenterologist is appropriate when initial empirical therapy fails, red flags are present, or endoscopy reveals findings requiring specialist input. Same-day admission should be considered for patients unable to maintain hydration, those with significant bleeding, or those in whom a foreign body or perforation is suspected.

Esophageal cancer is uncommon but serious, and a low threshold for investigation is appropriate, particularly in patients over 50 with new symptoms. Coordinated care through a multidisciplinary team, ideally linked to a high-volume centre, improves staging accuracy and treatment planning, and the congress registration page lists upcoming educational opportunities for clinicians wanting to update their knowledge.

The practical takeaway is straightforward: take a careful history, separate odynophagia from dysphagia and globus, treat the most likely cause empirically when safe to do so, and refer promptly when red flags emerge, when initial therapy fails, or when endoscopy reveals anything beyond straightforward inflammation.